BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Approvals
AstraZeneca PLC (AZN)'s Cancer Drug Pipeline Gets Boost From European Green Light 10/24/2014
Baxter International, Inc. (BAX)'s Hemophilia A Drug Obizur Wins FDA Approval 10/24/2014
Europe Approves Clinuvel's Novel Australian Drug Developed For Rare Sun Disease 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion 10/22/2014
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM® 10/22/2014
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval 10/22/2014
Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients 10/21/2014
BioSpecifics Technologies Corporation (BSTC) Announces FDA Approval Of sBLA For XIAFLEX® For The Concurrent Treatment Of Two Dupuytren's Contracture Cords 10/21/2014
Halozyme Therapeutics, Inc. (HALO) Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 10/20/2014
Pfizer (PFE) Release: FDA Approves Abuse Deterrent Labeling For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII 10/20/2014
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product 10/20/2014
InterMune, Inc. (ITMN) Wins FDA Approval For Lung Drug At Center Of Roche (RHHBY) Deal 10/17/2014
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/17/2014
FDA Approves Gilead Sciences, Inc. (GILD)'s New Hepatitis C Drug Harvoni 10/15/2014
FDA Approves Expanded Use Of Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® For Lymphatic Mapping In Solid Tumors 10/15/2014
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV 10/14/2014
Eisai Inc. (ESALF.PK) Grabs FDA Approval For Chemotherapy Side Effect Drug AKYNZEO® 10/13/2014
Sunascen Therapeutics Gets FDA's Green Light For The New Over The Counter NAUS-EASE® Tablets 10/10/2014
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea 10/10/2014
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) For Injection For Previously Untreated Patients With Mantle Cell Lymphoma 10/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis 10/8/2014
Novartis AG (NVS) Release: (Pr)Lucentis® (ranibizumab) Approved By Health Canada To Treat Vision Loss Resulting From Choroidal Neovascularization In Pathologic Myopia (mCNV)(1) 10/8/2014
Ferring Pharmaceuticals Receives FDA Approval For New Cranberry Flavor Of PREPOPIK® (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid) 10/7/2014
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For Macular Edema Following Retinal Vein Occlusion (RVO) 10/7/2014
AbbVie (ABBV)'s HUMIRA® (adalimumab) Receives U.S. FDA Approval For Extension Of Polyarticular Juvenile Idiopathic Arthritis Indication To Patients Ages 2 And Older 10/6/2014
Ganeden Biotech Release: GanedenBC30 Probiotic Approved In Japan, Taiwan, India & Philippines 10/6/2014
Diplomat Release: XTANDI® (enzalutamide) Receives Expanded Approval From FDA For Treatment Of Metastatic Castration-Resistant Prostate Cancer 10/1/2014
U.S. FDA Approves Dual-Chamber Syringe For Abilify Maintena® (Aripiprazole) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia 9/30/2014
Cesca Therapeutics Announces Approval Of Its AXP ® Autoxpress ® System In Taiwan 9/29/2014
Allergan Inc. (AGN) Announces FDA Approves Revised Indication For OZURDEX ® (Dexamethasone Intravitreal Implant) 0.7 Mg For The Treatment Of Diabetic Macular Edema 9/29/2014
Alimera Sciences (ALIM), pSivida Corp (PSDV) Eye Implant Finally Wins FDA Approval 9/29/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Announces FDA Approval Of Spiriva® Respimat® (Tiotropium Bromide) Inhalation Spray For The Maintenance Treatment Of COPD 9/25/2014
AbbVie (ABBV)'s HUMIRA® (adalimumab) Receives U.S. FDA Approval For The Treatment Of Pediatric Patients With Moderately To Severely Active Crohn's Disease 9/25/2014
Celgene (CELG) Announces The Swissmedic Approval Of ABRAXANE® For Treatment Of Both Metastatic Pancreatic And Breast Cancers 9/25/2014
Celgene (CELG)'s Psoriasis Drug Wins Approval For New Indication 9/24/2014
Noven Pharmaceuticals Inc. Receives FDA Approval Of A New Indication With A New Dose For Minivelle® (Estradiol Transdermal System) 9/24/2014
Eli Lilly and Company (LLY) Gets Thumbs Up From FDA For Diabetes Drug Trulicity 9/22/2014
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval 9/19/2014
FDA Approves AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR)'s MOVANTIK™ For Opioid-Induced Constipation 9/16/2014
EPIRUS’ Remicade® Biosimilar Receives Final Approvals In India 9/16/2014
FDA Approves Baxter International, Inc. (BAX), Halozyme Therapeutics, Inc. (HALO)'s HYQVIA 9/15/2014
FDA Approves Orexigen Therapeutics, Inc. (OREX)'s Long-Awaited Weight Loss Drug Contrave 9/12/2014
Lannett Company, Inc. (LCI) Receives FDA Approval For Oxycodone Hydrochloride Oral Solution USP, 100 mg Per 5 mL 9/11/2014
FDA Approves Keryx Biopharmaceuticals (KERX)' Kidney Drug Ferric Citrate With Warnings, Shares Crash 9/9/2014
ThromboGenics NV (TBGNF)' JETREA® Gains Approval In South Korea 9/8/2014
FDA Approves Merck & Co. (MRK)'s New-Kind Of Cancer Drug Keytruda 9/8/2014
DS Healthcare Group Obtains Regulatory Approval In Middle East 9/4/2014
China’s Food And Drug Administration Has Cleared NovaBay Pharmaceuticals, Inc. (NBY)’s Neutrophase Skin And Wound Cleanser For Sale Throughout Mainland China By NovoBay’s Partner, China Pioneer Pharma 9/3/2014
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema 9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures 9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease 9/2/2014
INNOPHARMA Announces FDA Approval Of Decitabine For Injection, A Generic Version Of DACOGEN® 8/29/2014
Pfizer Inc. (PFE) And FDA Announce Protalix Biotherapeutics, Inc. (PLX) Approval Of Pediatric Indication For ELELYSO™ (taliglucerase alfa) For Injection, For Intravenous Use For The Treatment Of Type 1 Gaucher Disease 8/29/2014
TWi Pharmaceuticals, Inc. Receives FDA Final Approval On Generic Megestrol Acetate 125mg/Ml Oral Suspension 8/28/2014
SciClone Pharmaceuticals, Inc. (SCLN) And BTG plc (BTG.L) Announce That DC Bead® Has Been Approved By China Food And Drug Administration 8/28/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: Health Canada Approves Eloctate™, The First Therapy To Extend The Interval Between Prophylactic Infusions In Hemophilia A 8/26/2014
Fresenius Kabi AG Receives FDA Approval For Kabiven® And Perikabiven® 8/26/2014
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE)'s ViiV Healthcare Wins Approval For HIV Combo Drug 8/25/2014
Iroko Pharmaceuticals Gains FDA Approval Of ZORVOLEX® For Management Of Osteoarthritis Pain 8/25/2014
GlaxoSmithKline (GSK) Receives FDA Approval Of An Additional Promacta® (Eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia (SAA) Who Have Had An Insufficient Response To Immunosuppressive Therapy (IST) 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
FDA Approves Use Of Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis To Treat Leg, Lung Clots 8/22/2014
GlaxoSmithKline (GSK)'s Asthma Treatment Wins FDA Approval 8/21/2014
Amerigen Pharmaceuticals Announces That Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., Has Received Chinese FDA (CFDA) Approval And Has Subsequently Launched Its Generic Mecobalamin 0.5 Mg Tablets Into The China Domestic Market 8/20/2014
FDA Approves Genzyme Corporation (GENZ)'s Gaucher Disease Pill Cerdelga 8/20/2014
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Sclerosis Drug Plegridy 8/19/2014
Merck & Co. (MRK) Wins FDA Approval For New Type Of Sleeping Pill 8/15/2014
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014
B.Braun Medical Receives FDA Approval For Nutrilipid® 20% 8/13/2014
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) Retreatment In Patients With Multiple Myeloma 8/11/2014
FDA Green Lights Johnson & Johnson (JNJ)'s Diabetes Drug Invokamet 8/11/2014
FDA Approves The Medicines Company (MDCO)'s Acute Skin Infection Drug Orbactiv 8/7/2014
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014
Health Canada Approves Celgene Corporation (CELG)'s ABRAXANE® Plus Gemcitabine For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 8/6/2014
European Commission (EC) Approves Roche (RHHBY)’s Avastin For Platinum-Resistant Recurrent Ovarian Cancer 8/6/2014
FDA Approves Baxter International, Inc. (BAX)’s FLEXBUMIN 5%, First And Only 5% Human Albumin Solution In A Flexible Container 8/4/2014
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients 8/1/2014
FDA Green Lights Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes 8/1/2014
Vertex Pharmaceuticals Incorporated (VRTX) Receives European Approval For KALYDECO™ (ivacaftor) In Eight Non-G551D Gating Mutations 8/1/2014
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For The Treatment Of Diabetic Macular Edema (DME) 7/31/2014
Roche (RHHBY)’s Gazyvaro Approved In Europe For Patients With The Most Common Type Of Leukemia 7/29/2014
Bristol-Myers Squibb Company (BMY) Release: European Commission Approves Eliquis (Apixaban) For The Treatment Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE), And Prevention Of Recurrent DVT And PE 7/29/2014
U.S. FDA Grants Regular (Full) Approval For Pharmacyclics, Inc. (PCYC)'s IMBRUVICA® For Two Indications 7/28/2014
Aqua Pharmaceuticals Announces FDA Approval Of ACTICLATE™ (Doxycycline Hyclate USP) Tablets, 150 Mg And 75 Mg 7/28/2014
FDA Approves Purdue Pharma L.P.’s Hard-to-Abuse Narcotic Painkiller 7/28/2014
FDA Approves Gilead Sciences, Inc. (GILD)'s Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 7/23/2014
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014
FDA Approves Eagle Pharmaceuticals (EGRX)' Ryanodex® For The Treatment Of Malignant Hyperthermia 7/23/2014
Starpharma: VivaGel® Condom Receives TGA Device Certification - Launch Preparations To Follow 7/21/2014
Pharming Group (PHGUF.PK), Salix Pharmaceuticals, Ltd. (SLXP) Wins FDA Approval For Ruconest® 7/17/2014
Purdue Pharma L.P. Receives FDA Approval For 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 7/16/2014
Hamilton Thorne, Inc. Receives Notification Of Grant Of Patent Right And CFDA Approval To Market Its LYKOS(R) Laser System In China 7/16/2014
MediWound (MDWD) Announces NexoBrid Marketing Approval From Israeli Ministry of Health 7/16/2014
Ion Beam Applications (IBA) Receives FDA Approval Of Its New Compact Gantry Clearing The Way For Proteus®ONE 7/16/2014
Octapharma USA, Inc. Announces FDA Approval Of Octagam 10%, Expanding Its Immune Globulin Therapy Portfolio 7/15/2014
Medac Pharma, Inc. Wins FDA Approval Of Rasuvo Injection For Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 7/14/2014
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval Of APTIOM(TM) (eslicarbazepine acetate) As A Once-Daily Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy 7/11/2014
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Swissmedic Approves AMITIZA® (Lubiprostone) For The Treatment Of Opioid-Induced Constipation 7/8/2014
Protein Sciences Corporation Receives Approval From FDA For 2014/15 Formulation Of Flublok® Influenza Vaccine 7/8/2014
FDA Approves Anacor Pharmaceuticals, Inc. (ANAC)’ KERYDIN™ (Tavaborole) Topical Solution, 5% For The Treatment Of Onychomycosis Of The Toenails 7/8/2014
Japan Becomes First Country To Approve Roche (RHHBY)'s Alectinib For People With A Specific Form Of Advanced Lung Cancer 7/7/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIM™ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014
Bristol-Myers Squibb Company (BMY) Release: Japan Approves First All-Oral, Interferon- And Ribavirin-Free Hepatitis C Treatment, Daklinza® (Daclatasvir) And Sunvepra®(Asunaprevir) Dual Regimen 7/7/2014
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014
FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014
FDA Green Lights Spectrum Pharmaceuticals, Inc. (SPPI)'s Beleodag To Treat Rare Form Of Lymphoma 7/3/2014
FDA Approves MannKind Corporation (MNKD)'s Much Anticipated Diabetes Therapy Afrezza 7/1/2014
Genzyme Corporation (GENZ)’s Lemtrada Approved In Argentina For Treatment Of Multiple Sclerosis 6/30/2014
Flamel Technologies (FLML) Wins FDA Approval For VAZCULEP 6/30/2014
pSivida Corp (PSDV)'s Iluvien Gets Marketing Authorizations In 10 More EU Countries 6/30/2014
India's Ranbaxy Laboratories (RANBAXY.BO) Wins FDA Approval For Novartis AG (NVS)'s Diovan Generic 6/27/2014
Paragon BioTeck Grabs FDA Approval For Comfortear Lacrisolve Absorbable Punctum Plug 6/26/2014
Intuitive Surgical, Inc. (ISRG) Receives CE Mark For The Da Vinci® Xi™ Surgical System 6/25/2014
NeuroMetrix, Inc. (NURO) Reports Japan Regulatory Approval For NC-stat DPNCheck 6/24/2014
Hengrui Medicine Granted Approval To Market Cancer Drug In U.S. 6/24/2014
Cubist Pharmaceuticals, Inc. (CBST) Wins FDA Approval For MRSA Antibiotic Sivextro 6/24/2014
Rockwell Medical (RMTI) Receives FDA Approval For Calcitriol 6/23/2014
Roche (RHHBY) Medicine Gazyvaro Granted Approval For The Therapy Of Patients With Previously Untreated Chronic Lymphocytic Leukemia And Co-Existing Medical Conditions In Switzerland 6/18/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In Europe For The Prevention Of Anal Cancer 6/18/2014
Valeant Pharmaceuticals International (VRX) Receives U.S. FDA Clearance For Restylane® Silk 6/17/2014
Navidea Biopharmaceuticals (NAVB) Release: FDA Approves Lymphoseek To Help Determine The Extent Of Head And Neck Cancer In The Body 6/13/2014
Breckenridge Pharmaceutical, Inc. Announces Approval For Duloxetine Delayed-Release Capsules 6/13/2014
FDA Approves Bayer HealthCare (BAY)'s Gadavist (Gadobutrol) Injection As The First Magnetic Resonance Contrast Agent For Evaluation Of Breast Cancer In The United States 6/12/2014
FDA Green Lights Strativa Pharmaceuticals' Nascobal® (Cyanocobalamin, USP) Nasal Spray Single-Use Device 6/11/2014
Acella Pharmaceuticals, LLC Announces Approval Of Tranexamic Acid Injection 6/10/2014
North Carolina's BioDelivery Sciences International (BDSI) Wins FDA Approval For Opiod Dependence Drug Bunavail 6/10/2014
Teva Pharmaceutical Industries Limited (TEVA): FDA Clears Expanded Label For AZILECT® For Treatment Across All Stages Of Parkinson's Disease 6/9/2014
FDA Approves Valeant Pharmaceuticals International (VRX) Toenail Fungus Drug Jublia® 6/9/2014
FDA Approves Biogen, Inc.'s Hemophilia A Drug Eloctate 6/9/2014
Boehringer Ingelheim Corporation's Pradaxa® Wins EU Approval To Treat Deep Vein Thrombosis And Pulmonary Embolisms 6/6/2014
Janssen-Cilag International NV Release: INVEGA® Receives European Commission Approval To Extend Its Adult Indication For Treatment Of Schizophrenia To Include Adolescents Aged 15 Years And Older 6/4/2014
Omeros Corporation (OMER) Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures 6/2/2014
Bayer HealthCare (BAY) Receives EU Approval For Nexavar (Sorafenib) For The Treatment Of Differentiated Thyroid Cancer 5/30/2014
Protalix Biotherapeutics, Inc. (PLX) Announces ELELYSO™ (Taliglucerase Alfa) Approved In Canada For The Treatment Of Gaucher Disease In Both Adult And Pediatric Patients 5/30/2014
Trimel Pharmaceuticals (Formerly Known As Trimel BioPharma) (TRL.TO) Rises On FDA Approval For Natesto™ Nasal Gel 5/29/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids 5/29/2014
Nuvo Research Inc. (NRI.TO) Announces FDA Approval Of Third-Party Generic Of PENNSAID 1.5% 5/29/2014
FDA Approves Durata Therapeutics, Inc.  (DRTX)'s Dalvance To Treat Skin Infections 5/28/2014
Amgen (AMGN) Colorectal Cancer Drug Vectibix Gains Expanded Approval From The FDA 5/28/2014
Janssen Inc.'s First-In-Class Type 2 Diabetes Medication Approved In Canada 5/27/2014
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval For QVAR® 5/27/2014
European Commission (EC) Approves Boehringer Ingelheim Corporation-Eli Lilly and Company (LLY)'s Jardiance® Tablets 5/23/2014
Protalix Biotherapeutics, Inc. (PLX) Announces ELELYSO™ (Taliglucerase Alfa) Approved In Australia For The Treatment Of Gaucher Disease In Both Adult And Pediatric Patients 5/22/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Entyvio Wins FDA Approval For Severe Colitis 5/22/2014
Merck Animal Health Announces FDA Approval Of BRAVECTO™ (fluralaner) 5/20/2014
Novartis AG (NVS) Release: First Myelofibrosis Medication For Life-Threatening Blood Cancer Approved In Singapore 5/15/2014
Actavis (ACT) Receives Final Approval For Generic Version Of Exalgo® 5/14/2014
Perrigo Company (PRGO) Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray 5/12/2014
FDA Approves Bayer HealthCare (BAY)'s Kogenate® FS Antihemophilic Factor VIII (Recombinant) For Routine Prophylaxis In Adults With Hemophilia A 5/12/2014
Merck & Co., Inc. (MRK) Release: FDA Approves ZONTIVITY™ (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease 5/12/2014
FDA Green Lights Novel Merck & Co., Inc. (MRK) Drug To Prevent Heart Attacks And Strokes 5/12/2014
FDA Approves Genentech (RHHBY) And Novartis AG (NVS)'s Xolair For Treatment Of Chronic Hives 5/8/2014
AstraZeneca PLC (AZN) Gets A Lift In Pfizer Inc. (PFE) Fight As FDA Approves Heart Pill Epanova 5/7/2014
TNI BioTech Obtains Drug Approval For Sale Of Low Dose Naltrexone (LDN) From Government Of Malawi 5/6/2014
Alexion Pharmaceuticals Inc. (ALXN) Wins FDA Approval Of Soliris® Accelerated Approval To Regular Approval 5/6/2014
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s SYNRIBO® For Injection For Home Administration 5/5/2014
FDA Approves Ibalizumab Manufactured By WuXi PharmaTech Co., Ltd. For Treatment Of Patients On Expanded Access 5/5/2014
FDA Approves GlaxoSmithKline (GSK)'s COPD Drug Incruse™ Ellipta® 5/2/2014
Novartis AG (NVS) Gains FDA Approval For Lung Cancer Drug Zykadia™ 5/1/2014
Health Canada Approves EGRIFTA™ (Tesamorelin For Injection) And Theratechnologies Inc. (TH.TO) Regains Canadian Commercialization Rights To EGRIFTA™ 4/30/2014
FDA Green Lights Rare Disease Therapeutics, Inc.'s New Liquid Form To Treat Patients With Acute Lymphoblastic Leukemia (ALL) 4/30/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces European Commission Approval For VIMIZIM® (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In Patients Of All Ages 4/28/2014
Janssen-Cilag International NV (JNJ) Release: VOKANAMET® (Canagliflozin And Immediate Release Metformin Hydrochloride Fixed Dose Combination) Approved In The European Union For Treatment Of Adults With Type 2 Diabetes [1] 4/25/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain 4/24/2014
Sunascen Therapeutics Gets FDA's Green Light For The New Over-The-Counter NAUS-EASE® Tablets 4/24/2014
FDA Approves Janssen Biotech Inc. (JNJ)'s SYLVANT™ For Rare Castleman's Disease 4/24/2014
Baxter International, Inc. (BAX) Announces FDA Approval Of ADVATE (Antihemophilic Factor [Recombinant]) With BAXJECT III Reconstitution System 4/23/2014
FDA Approves Eli Lilly and Company (LLY)'s Cyramza For Stomach Cancer 4/23/2014
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014
FDA OKs Merck & Co., Inc. (MRK) Tablet To Reduce Ragweed Allergies 4/18/2014
GlaxoSmithKline (GSK) Announces Approval In Canada For Incruse™ Ellipta™ (Umeclidinium) As A Treatment For COPD 4/17/2014
FDA Approves Merck & Co., Inc. (MRK)'s Grass Pollen Pill GRASTEK® 4/15/2014
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014
Par Pharmaceutical, Inc. Begins Shipment Of Potassium Chloride Extended-Release Capsules 4/8/2014
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: FDA Approves Pradaxa® (Dabigatran Etexilate Mesylate) For Treatment And Reduction In The Risk Of Recurrence Of Deep Venous Thrombosis And Pulmonary Embolism 4/7/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014
Dyax Corp. (DYAX) Receives FDA Approval To Expand Use Of KALBITOR® (Ecallantide) For The Treatment Of Acute Attacks Of Hereditary Angioedema To Patients 12 Years Of Age And Older 4/4/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Luxembourg 4/3/2014
FDA Approves Kaleo's Hand-Held Auto-Injector To Reverse Opioid Overdose 4/3/2014
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Hemophilia B Drug Alprolix 3/31/2014
FDA OKs Janssen Pharmaceutical Inc. 's Topamax For Migraine Prevention In Adolescents 3/31/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014
Pfizer Inc. (PFE) Statement On FDA Approval Of Over-the-Counter Nexium® 24HR 3/31/2014
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014
European Commission (EC) Approves Roche (RHHBY)'s New Formulation Of Blood Cancer Drug 3/28/2014
Bay Area's Exelixis, Inc. (EXEL) Gets A Boost, Wins Approval For COMETRIQ® In European Union For Treatment Of MTC 3/27/2014
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014
Celgene Corporation (CELG) Wins FDA Approval For Pill To Treat Psoriatic Arthritis 3/25/2014
Novartis AG (NVS) Announces FDA Approval Of Xolair® (Omalizumab) For Chronic Idiopathic Urticaria (CIU), A Form Of Chronic Hives 3/24/2014
Taiho Pharmaceutical's Lonsurf® (Trifluridine And Tipiracil Hydrochloride) Tablets Approved In Japan For Treatment Of Advanced Metastatic Colorectal Cancer 3/24/2014
Health Canada Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Long-Acting ALPROLIX™ Therapy For Hemophilia B 3/24/2014
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014
Genzyme Corporation (GENZ)'s Lemtrada™ Approved In Brazil For Treatment Of Multiple Sclerosis 3/21/2014